| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 559.11B | 561.00B | 512.48B | 487.13B | 399.59B | 323.81B |
| Gross Profit | 44.49B | 46.27B | 44.03B | 39.23B | 29.11B | 24.01B |
| EBITDA | 16.11B | 18.86B | 20.15B | 18.54B | 10.95B | 9.90B |
| Net Income | 4.83B | 7.47B | 7.00B | 7.09B | 5.96B | 4.05B |
Balance Sheet | ||||||
| Total Assets | 305.80B | 310.02B | 291.70B | 269.43B | 241.96B | 190.38B |
| Cash, Cash Equivalents and Short-Term Investments | 44.46B | 44.42B | 39.92B | 32.99B | 33.44B | 40.20B |
| Total Debt | 109.17B | 115.31B | 118.29B | 107.39B | 94.26B | 56.65B |
| Total Liabilities | 207.33B | 209.96B | 200.68B | 184.33B | 160.30B | 114.12B |
| Stockholders Equity | 84.46B | 85.94B | 84.33B | 80.89B | 77.65B | 73.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.89B | 11.87B | -5.32B | -35.19B | 16.25B |
| Operating Cash Flow | 0.00 | 20.20B | 15.67B | -363.00M | -26.63B | 20.13B |
| Investing Cash Flow | 0.00 | 61.00M | -6.61B | -5.60B | -16.17B | 13.54B |
| Financing Cash Flow | 0.00 | -16.11B | -3.00B | 3.71B | 34.49B | -15.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥64.66B | 15.26 | 12.96% | 1.36% | 18.44% | 26.68% | |
71 Outperform | ¥391.02B | 13.71 | ― | 1.02% | 29.60% | 24.39% | |
69 Neutral | ¥100.55B | 10.73 | ― | 0.93% | 28.52% | 43.16% | |
63 Neutral | ¥72.69B | 17.02 | ― | 1.85% | 3.60% | -17.45% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥83.86B | 9.29 | ― | 4.31% | 4.77% | -36.62% | |
50 Neutral | ¥106.18B | 43.14 | ― | 2.45% | 4.60% | -21.64% |